Development of Antibody-Based Cancer Therapeutics
3 November 2019
Antibody-based therapeutics represent an important advancement in the progress of cancer treatment options. The discovery and development of therapeutic monoclonal antibodies offers the potential promise of personalized treatment with high specificity and safety. With treatments already available for several cancer types, this class of biologics offers one of the most successful therapeutic strategies for both hematologic cancers and solid tumors in recent years.
In this application note compendium, we look at some of the successful discovery and development methods for monoclonal antibody-based treatments for cancer. These methods take advantage of cutting-edge technologies, such as the Intellicyt® iQue Screener PLUS from Sartorius, which enables rapid identification and characterization of candidate molecules with superior target reactivity and optimized functionality.